Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
88,184,599
-
Share change
-
-827,437
-
Total reported value
-
$10,564,179,360
-
Put/Call ratio
-
87%
-
Price per share
-
$119.80
-
Number of holders
-
407
-
Value change
-
-$129,808,671
-
Number of buys
-
237
-
Number of sells
-
164
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2018
As of 31 Dec 2018,
DEXCOM INC - Common Stock (DXCM) was held by
407 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,184,599 shares.
The largest 10 holders included
Vanguard Group Inc, JPMORGAN CHASE & CO, MORGAN STANLEY, BlackRock Inc., FMR LLC, BAILLIE GIFFORD & CO, BROWN ADVISORY INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and HealthCor Management, L.P..
This page lists
407
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.